SB202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinases with IC50 values of 50 nM and 100 nM for p38α and p38β, respectively.

Goals and Objectives: (1) Increase awareness of and access to health care and risk prevention among underserved children and families in partnership with other ...

SB202190. Synonyms: FHPI. Catalog No.S1077 Purity: 99.99%. SB202190 is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM in cell-free ...

View and buy high purity SB202190 (FHPI) from AOBIOUS, the leading supplier of life science reagents.

This is a laboratory product for research use only. Not for personal consumption. It will not be effective and is dangerous for personal use.

SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38?/? with IC50 of 50 nM/100 nM in cell-free assays, sometimes used instead of SB 203580 to ...

However, FHPI inhibited HCMV DNA replication and late gene expression. The inhibitory effect of FHPI was reversible, as demonstrated by the induction of HCMV ...

SB 202190 (FHPI) is a selective and cell-permeable inhibitor of p38 MAPK (IC50s: 50/100 nM for p38α/p38β).

Buy SB 202190, Free Base (FHPI, SB202190, 4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazo, CAS: 152121-30-7, item number: LC-S-1700_100mg ...